Aethlon Medical (AEMD) Asset Writedowns and Impairment (2010 - 2020)

Aethlon Medical (AEMD) posted Asset Writedowns and Impairment of -$67892.0 for Q1 2020, down 392.89% on a QoQ basis from $23180.0 in Q4 2019.

Aethlon Medical (AEMD) Asset Writedowns and Impairment (2010 - 2020) Analysis & Trends

Aethlon Medical's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at -$67892.0 for Q1 2020.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$67892.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$44712.0 (changed N/A YoY) and the FY2026 annual result came in at $294026.0, up 4.56% from the prior year.
  • Asset Writedowns and Impairment was -$67892.0 for Q1 2020 at Aethlon Medical, down from $23180.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $23180.0 in Q4 2019 and bottomed at -$67892.0 in Q1 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.51 Bn 174.22 Bn 6.27 Bn
2 Stryker 128.20 Bn 125.32 Bn 3.81 Bn
3 Medtronic 107.69 Bn 98.47 Bn 6.41 Bn
4 Boston Scientific 68.05 Bn 66.59 Bn 3.61 Bn
5 Edwards Lifesciences 47.52 Bn 43.85 Bn 1.29 Bn
6 GE HealthCare Technologies 28.46 Bn 26.17 Bn 1.98 Bn
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn
8 Smith & Nephew 26.73 Bn 26.15 Bn -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn
10 Aethlon Medical 393,381.70 393,381.70 -

Historic Data

Download Data
DateValue
Mar 31, 2020 -67,892.00
Mar 31, 2020 -67,892.00
Dec 31, 2019 23,180.00
Dec 31, 2019 23,180.00
Jun 30, 2012 11,846.00
Jun 30, 2012 11,846.00
Mar 31, 2012 156,100.00
Mar 31, 2012 156,100.00
Jun 30, 2011 538,736.00
Jun 30, 2011 538,736.00
Mar 31, 2011 -443,366.00
Mar 31, 2011 -443,366.00
Dec 31, 2010 20,362.00
Dec 31, 2010 20,362.00